2018 Expert Consensus on the Management of Adverse Effects of Antiplatelet Therapy for Acute Coronary Syndrome in Taiwan

Antiplatelet therapy is a key component in the treatment of acute coronary syndrome (ACS). The management of ACS has evolved considerably over recent years with the development of newand more potent antiplatelet agents. Clinical trials on ACS have demonstrated that potent antiplatelet agents can mor...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Acta Cardiologica Sinica 2018-05, Vol.34 (3), p.201-210
Hauptverfasser:	Li, Yi-Heng, Fang, Chih-Yuan, Hsieh, I-Chang, Huang, Wei-Chun, Lin, Tsung-Hsien, Sung, Shih-Hsien, Chiu, Chiung-Zuan, Wu, Chiung-Jen, Shyu, Kou-Gi, Chang, Po-Yuan, Fang, Ching-Chang, Lu, Tse-Min, Chen, Ching-Pei, Tai, Wei-Chen, Sheu, Chau-Chyun, Wei, Kai-Che, Huang, Yi-Hsiu, Wu, Hsing-Mei, Hwang, Juey-Jen Hwang
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute coronary syndrome Antiplatelet therapy Expert consensus Guidance MEDLINE Review SCI Scopus
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!